Allevi designs 3D bioprinters that are capable of printing human tissue, allowing scientists to study the body outside the body. Constructs within hydrogels and microfluidic systems are designed to allow for personalized disease diagnostics to test both efficacy and safety. By specifically targeting personalized diagnostics, Allevi aims to empower pathologists and oncologists around the world to make more informed decisions by giving them the ability to create a more physiologically relevant model using a patient’s own cells.
